In partnership with
December 22, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s spine is simple: Schedule III now lives in the administrative record, and the next gatekeeper is the judge who decides whether the rule survives first contact with litigation. We also track how states are tightening the screws, from Ohio’s rewrite to New York’s new marketing rules and the early 2026 repeal machinery revving up.
Today’s edition is supported by Morning Brew and Fisher Investments. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.
⚖️ Court risk first
🧾 280E timing reality
🗳️ Ballot fights warming up
Paper beats press conferences.
Business news worth its weight in gold
You know what’s rarer than gold? Business news that’s actually enjoyable.
That’s what Morning Brew delivers every day — stories as valuable as your time. Each edition breaks down the most relevant business, finance, and world headlines into sharp, engaging insights you’ll actually understand — and feel confident talking about.
It’s quick. It’s witty. And unlike most news, it’ll never bore you to tears. Start your mornings smarter and join over 4 million people reading Morning Brew for free.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: President Trump’s executive order put Schedule III back into motion, and the next moves now belong to the federal bureaucracy. Reporting suggests DOJ could try to close out the paused hearing posture and publish a final scheduling rule on an accelerated track. The same reporting makes the risk obvious: opponents are prepared to sue, and a court stay can freeze the change even after a final rule is issued. Republican state attorneys general have already organized their pushback around youth exposure and impaired driving, and they are positioning themselves to influence how the record is built and how agencies explain the tradeoffs. On Capitol Hill, Sen. Ted Budd says he personally called Trump to oppose rescheduling, an early sign that internal Republican resistance will keep showing up in hearings, letters, and appropriations pressure. Running the clock out seems to be an effective D.C. gameplan.
💡 Why It Matters: Schedule III becomes financially real on the effective date of a final rule, and that effective date is what unlocks the tax consequences everyone keeps talking about. The temptation is to sprint, because speed feels like certainty, and speed also creates mistakes that judges can punish. Opponents do not need to pass a new law to slow this down. They can grind the gears through oversight, funding levers, and demands for data that reshape the narrative the agencies need to defend. State attorneys general can amplify that pressure, and their framing travels easily into statehouses that already treat marijuana and intoxicating hemp as the same problem. The White House chose a medical and research posture, which means standards, definitions, and enforcement credibility are now part of the scheduling story.
🧠 THC Group Take: Patience is a virtue? The press conference was a big deal, and everyone in the room said all the right things praising the President for his leadership. When you woke up this morning, marijuana is still a Schedule I drug. Bureaucracy still has work to do to finish the job, just as it did a few years back when President Biden tried to tee up the same move.
DOJ and DEA now have to put this into a form that can survive the inevitable dark-money Kevin Sabet-led Smart Approaches to Marijuana challenge. Those opponents already know which buttons to push, too. You can hear the outline forming: youth access, impaired driving, mental health, hospital costs, plus a quiet fixation on what 280E relief looks like in the real world once it starts showing up on balance sheets. You’re already reading some of their planted editorials and op-eds.
That is why the timeline matters more than the applause. A fast rule that trips on procedure is a gift. A slower rule with a clean record is harder to stop. The White House can keep the center if it writes like it means it, with standards that reward disciplined products and disciplined channels, and with enforcement posture that does not pretend every THC product is the same.
If you are building a plan off this moment, build it like an adult. Assume there will be litigation. Assume there will be oversight. Keep your compliance posture tight enough that a hostile hearing produces boring answers. The winners will be the ones who can show their work when the politics shift from celebration to scrutiny.
Fast-moving headlines, flagged for what matters.
Have you heard? President Trump signed an executive order directing the Attorney General to drive the federal process toward moving marijuana from Schedule I to Schedule III. The order leans on the medical-use record and points agencies back to the administrative pathway already underway at DOJ and DEA, including the pending hearing track. It also opens a federal lane for hemp-derived CBD through health agencies, with a CMS pilot concept described on a timeline that could begin as early as April. Markets stayed cautious, with investors focusing on timing and the missing banking fix. 280E relief stays out of reach until a final rule is issued and takes effect. (Forbes)
AG Pam Bondi has public marching orders to move quickly, and the schedule still has no firm end date. Administrative law experts say DOJ could wrap the paused hearing process and publish a final rule fast, including scenarios measured in days. Speed has a price, though: legalization opponents are already lining up litigation, and a court stay could freeze the tax upside even if the rule is published. A messy record or procedural slip would hand challengers oxygen and time. Finance teams can run post-280E models today and still need a delay plan that assumes litigation. (MJBizDaily)
A coalition of Republican attorneys general moved quickly to attack Trump’s executive order and frame it as a youth-access and impaired-driving problem. The group includes Indiana, Iowa, Idaho, Kansas, Louisiana, Nebraska, Oklahoma, and Wyoming, which gives the message a multi-state law enforcement posture instead of a lone dissent. Nebraska AG Mike Hilgers said the coalition will keep pressing the administration on public health and safety. South Dakota AG Marty Jackley said state AGs joined a White House call and stressed the order leaves federal prohibition intact for current markets. Those state voices now have a coordinated platform to push Congress and agencies toward tighter guardrails. (Marijuana Moment)
Sen. Ted Budd says he personally called President Trump to oppose marijuana rescheduling, undercutting Trump’s line that no one urged him to stop. Budd said other lawmakers reached out too, and he has already led Senate opposition in writing. His point lands as agencies move from ceremony to process, since implementation choices give critics plenty of hooks. The White House is leaning on polling and medical framing, and Budd is signaling that internal GOP resistance stays live. Expect more Hill pressure for enforcement posture and youth-focused limits as the rulemaking proceeds. (Marijuana Moment)
Trump’s order points the administration toward a congressional update to how finished hemp cannabinoid products are defined, with an emphasis on full-spectrum CBD access under clearer federal guardrails. The text contemplates per-serving and per-container limits and ratio concepts, which rewards predictable dosing and clean labeling. It also pushes federal health agencies toward research methods that can support standards and consumer safeguards. That posture helps disciplined models and narrows the room for products built to exploit gray markets. Product designers who already live inside low-dose limits just got a clearer direction of travel. (Wisconsin Ag Connection)
Moving marijuana to Schedule III would not change the federal firearms prohibition for unlawful users of controlled substances under 18 U.S.C. § 922(g)(3). Marijuana would remain federally controlled, and state legality does not alter how federal gun law treats use and possession. Dealers still face compliance exposure on Form 4473, and industry groups are warning members to hold the line. A real shift would require a lawful medical channel tied to federally approved prescriptions rather than state-market use. Gun owners who use cannabis stay in the same federal risk posture while courts keep churning Second Amendment challenges. (The Reload)
Gov. Mike DeWine signed a sweeping rewrite of Ohio’s voter-passed adult-use law paired with a crackdown on intoxicating hemp products, with most changes set to take effect in 90 days. The law adds new crimes, requires marijuana to remain in original packaging, and directs drivers to store it in the trunk while traveling. It also caps potency at 70% THC for extracts and 35% for flower, expands public smoking restrictions, and sets a 400-dispensary cap while keeping home grow at six plants per adult and 12 per residence. DeWine vetoed a one-year carveout that would have allowed 5 mg THC drinks through late 2026, pulling hemp beverages into the same enforcement lane. Retailers now face a near-term shelf decision and a longer-term question about whether licensed dispensaries can absorb the category. (Marijuana Moment)
Advocates launched a referendum effort to repeal Ohio’s new law rewriting parts of adult-use and tightening the state’s stance on intoxicating hemp. Organizers say they plan to use the full 90-day window to build a qualifying petition. A successful referendum filing would stay the law unless voters approve it at the next general election. That requires a serious signature operation and real money on a fast clock. Businesses now have to prepare for compliance shifts while watching a potential suspension effort take shape. (NBC4i)
New York’s Office of Cannabis Management says updated rules governing packaging, labeling, marketing, and advertising are now in effect following publication in the State Register. The changes give licensees more room to market, including explicit permission for rewards and loyalty programs and clearer rules for promotions and discounts. OCM clarified what counts as a billboard and reaffirmed billboard advertising remains prohibited, with existing billboard operators given until February 24, 2026 before compliance action. Several packaging and labeling provisions come with a six-month transition period, while other changes apply immediately. Retailers and regulators now have a cleaner playbook for incentives and enforcement calls that used to land in gray space. (Ganjapreneur)
Alabama’s ABC Board voted 2–1 to adopt emergency rules for the state’s new consumable hemp law, with the package set to take effect in January. Bill sponsor Rep. Andy Whitt criticized the emergency route as rushed and misaligned with legislative intent, and one board member voted no on process grounds. ABC officials argued emergency rules are needed to have enforceable guardrails in place at the start of 2026 while permanent rules move through the normal track. The emergency rules sunset in April, which sets up a second round of regulatory conflict soon after implementation begins. Retailers and manufacturers now face a compliance sprint followed by likely rewrites before spring. (AL.com)
Florida Attorney General James Uthmeier asked the Florida Supreme Court to review the proposed 2026 adult-use initiative for compliance with state ballot standards, and the court accepted the request and set a briefing schedule. Smart & Safe Florida says it has cleared one million signatures while fighting disputes over certification delays and a separate challenge tied to signatures the state deems invalid. The timeline moves quickly, with briefs due January 2nd, answers January 12th, and replies January 20th. Gov. Ron DeSantis has already previewed an aggressive opposition campaign, and Florida’s last adult-use attempt fell short of the 60% threshold. The first major fight now lives in court framing and ballot language, long before the Governor’s publicly funded attack ads begin. (Marijuana Moment)
Massachusetts election officials certified the first round of signatures for a 2026 ballot initiative that would roll back licensed adult-use cannabis sales and repeal home cultivation. The proposal keeps adult possession up to one ounce legal and preserves the medical program. The petition moves to the Legislature under the state’s indirect initiative process, where lawmakers can adopt it, decline it, or advance an alternative. If lawmakers take no action (the most likely outcome), proponents can return for another signature round to qualify it for the 2026 ballot. Financing and municipal negotiations tied to 2026 timelines now carry a visible repeal risk that will show up in deal terms. For observers, take this one seriously, as it is well-funded and ill-intentioned. (Worcester Business Journal)
A new Arizona campaign filed paperwork to put a repeal of the state’s recreational marijuana law on the 2026 ballot, led by Republican operative Sean Noble. The committee needs 255,949 valid signatures by July 2, which typically means collecting closer to 300,000 to survive verification. Noble says the signature effort alone could cost around $5 million, setting a high bar for organization and funding. He says he has backing from Smart Approaches to Marijuana (shocker!) and argues the industry’s marketing and potency reality outpaced what voters expected. Arizona’s market now has to price political rollback risk into expansion plans and municipal relationships heading into 2026. (Arizona Capitol Times)
Industry advocates describe a December 9th Oval Office meeting where Trump argued through Schedule III in real time, with supporters and opponents pressing him on tax relief, youth access, and mental health claims. ScottsMiracle-Gro CEO Jim Hagedorn said the session included a 40-minute call with House Speaker Mike Johnson and that Trump rejected a Schedule II compromise as a half step. Separate reporting describes a yearlong influence campaign that blended high-dollar fundraising, targeted polling, and direct access, with key players including Howard Kessler and Trulieve CEO Kim Rivers. The White House paired the move with a Medicare CBD pilot concept, which broadens the coalition beyond the cannabis industry and into seniors and health systems. Opponents now have a clearer map of who influenced the decision and where to apply pressure as DOJ and DEA move into the implementation phase. (CNBC. NewsNation)
13 Investment Errors You Should Avoid
Successful investing is often less about making the right moves and more about avoiding the wrong ones. With our guide, 13 Retirement Investment Blunders to Avoid, you can learn ways to steer clear of common errors to help get the most from your $1M+ portfolio—and enjoy the retirement you deserve.
From the hearing room to the comment section — we’re watching it all.
🥊 Mike Tyson praised Trump’s Schedule III move and immediately pushed for the next step, including clemency for nonviolent marijuana offenses and a clearer federal end state. His value here is reach: a cannabis operator with mass-market credibility can drag clemency and banking back into the conversation even when the White House stays focused on research and scheduling mechanics. (NewsNation)
🎥 Cannabix is using the rescheduling moment to market its THC breath-testing concept as an answer for workplaces and roadside enforcement. The company says it is not currently selling the product, so the real story is the policy pressure: states and employers want impairment tools, and vendors are lining up to fill the gap. (GlobeNewswire)
💸 Goodwin’s tax team says the real financial upside of Schedule III is 280E, since the rule only bites Schedule I and II activity and a final rescheduling would restore ordinary business deductions. The timing remains the entire game, because an executive order does not change scheduling by itself and tax posture stays put until the federal action is final and effective. (Goodwin)
🧠 A Mass General Brigham study of psychiatric emergency presentations at Massachusetts General Hospital found a sharp rise in THC-positive tests and cannabis use disorder diagnoses among adolescents after adult-use sales began. The paper will travel fast in potency, marketing, and youth-prevention debates because it ties cannabis exposure to teens already showing up in crisis settings. (Boston.com)